Location: New York, NY
CIK: 0001773195 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 13, 2025
Total Value: $746M (93.5% shares, 6.5% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 750,000 | $67.55M | 9.1% | — | — | Put | 78464A870 |
| XENE | XENON PHARMACEUTICALS INC | 1,161,237 | $45.52M | 6.1% | $40.65 | +1.7% | COM | 98420N105 |
| APGE | APOGEE THERAPEUTICS INC | 931,728 | $42.21M | 5.7% | $36.88 | +38.3% | COM | 03770N101 |
| ACLX | ARCELLX INC | 425,000 | $32.59M | 4.4% | $38.94 | +121.8% | COMMON STOCK | 03940C100 |
| ALKS | ALKERMES PLC | 1,100,000 | $31.64M | 4.2% | $25.75 | +11.6% | SHS | G01767105 |
| TEVA | TEVA PHARMACEUTICAL INDS LTD | 1,400,000 | $30.86M | 4.1% | $8.35 | — | SPONSORED ADS | 881624209 |
| — | VERONA PHARMA PLC | 660,000 | $30.65M | 4.1% | $16.19 | — | SPONSORED ADS | 925050106 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 82,500 | $25.46M | 3.4% | $147.99 | +90.1% | COM | 558868105 |
| CRNX | CRINETICS PHARMACEUTICALS IN | 460,000 | $23.52M | 3.2% | $27.88 | +100.7% | COM | 22663K107 |
| NUVL | NUVALENT INC | 285,000 | $22.31M | 3.0% | $69.61 | +34.2% | COM | 670703107 |
| SYRE | SPYRE THERAPEUTICS INC | 824,328 | $19.19M | 2.6% | $22.23 | +31.9% | COM NEW | 00773J202 |
| WVE | WAVE LIFE SCIENCES LTD | 1,500,000 | $18.55M | 2.5% | $6.27 | +113.0% | SHS | Y95308105 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 1,095,924 | $18.36M | 2.5% | $7.23 | — | SPONSORED ADS | 152309100 |
| VERA | VERA THERAPEUTICS INC | 425,000 | $17.97M | 2.4% | $35.96 | +23.1% | CL A | 92337R101 |
| NRIX | NURIX THERAPEUTICS INC | 940,083 | $17.71M | 2.4% | $10.36 | +121.2% | COM | 67080M103 |
| MESO | MESOBLAST LTD | 838,600 | $16.6M | 2.2% | — | — | Put | 590717401 |
| — | MERUS N V | 389,241 | $16.37M | 2.2% | $48.29 | — | COM | N5749R100 |
| — | COHERUS BIOSCIENCES INC | 16,625,000 | $16.19M | 2.2% | $0.67 | — | NOTE 1.500% 4/1 | 19249HAB9 |
| — | OMEROS CORP | 15,525,000 | $14.61M | 2.0% | $0.67 | — | NOTE 5.250% 2/1 | 682143AG7 |
| ESTA | ESTABLISHMENT LABS HLDGS INC | 279,445 | $12.87M | 1.7% | $57.41 | -24.1% | COM | G31249108 |
| ARVN | ARVINAS INC | 630,000 | $12.08M | 1.6% | $24.95 | -2.6% | COM | 04335A105 |
| — | KARYOPHARM THERAPEUTICS INC | 15,250,000 | $11.87M | 1.6% | $0.69 | — | NOTE 3.000%10/1 | 48576UAA4 |
| — | INOZYME PHARMA INC | 3,972,318 | $11M | 1.5% | $4.16 | — | COM | 45790W108 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 425,000 | $10.92M | 1.5% | $17.93 | +18.5% | ORDINARY SHARES | N62509109 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 4,500,000 | $10.57M | 1.4% | $4.28 | — | SPON ADS | 05280R100 |
| GERN | GERON CORP | 2,250,000 | $7.965M | 1.1% | $2.82 | +41.7% | COM | 374163103 |
| AMGN | AMGEN INC | 30,000 | $7.819M | 1.0% | — | — | Call | 031162100 |
| RZLT | REZOLUTE INC | 1,575,000 | $7.718M | 1.0% | $1.69 | +197.3% | COM NEW | 76200L309 |
| PRQR | PROQR THRAPEUTICS N V | 2,825,000 | $7.486M | 1.0% | $3.18 | 0.0% | SHS EURO | N71542109 |
| ORKA | ORUKA THERAPEUTICS INC | 368,698 | $7.149M | 1.0% | $34.26 | -28.8% | COM | 687604108 |
| AXSM | AXSOME THERAPEUTICS INC | 75,000 | $6.346M | 0.9% | $77.83 | +18.2% | COM | 05464T104 |
| ERAS | ERASCA INC | 2,499,431 | $6.274M | 0.8% | $2.16 | +27.1% | COM | 29479A108 |
| SLNO | SOLENO THERAPEUTICS INC | 130,000 | $5.843M | 0.8% | $51.06 | +1.5% | COM | 834203309 |
| — | TRAVERE THERAPEUTICS INC | 6,000,000 | $5.744M | 0.8% | $0.88 | — | NOTE 2.250% 3/0 | 89422GAA5 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 300,000 | $5.64M | 0.8% | $25.57 | -19.5% | COM | 04280A100 |
| BBIO | BRIDGEBIO PHARMA INC | 200,000 | $5.488M | 0.7% | $25.92 | -0.3% | COM | 10806X102 |
| NMRA | NEUMORA THERAPEUTICS INC. | 475,000 | $5.035M | 0.7% | — | — | Call | 640979100 |
| PTGX | PROTAGONIST THERAPEUTICS INC | 130,000 | $5.018M | 0.7% | $43.60 | 0.0% | COM | 74366E102 |
| MLYS | MINERALYS THERAPEUTICS INC | 350,000 | $4.309M | 0.6% | $12.33 | +6.0% | COM | 603170101 |
| CATX | PERSPECTIVE THERAPEUTICS INC | 1,300,000 | $4.147M | 0.6% | $10.58 | -22.9% | COM NEW | 46489V302 |
| SAVA | CASSAVA SCIENCES INC | 1,739,400 | $4.105M | 0.6% | — | — | Put | 14817C107 |
| AVTX | AVALO THERAPEUTICS INC | 550,765 | $4.092M | 0.5% | $10.74 | -0.5% | COM NEW | 05338F306 |
| PCSC | PERCEPTIVE CAP SOLUTIONS COR | 350,000 | $3.563M | 0.5% | $10.07 | +0.3% | CL A ORD SHS | G70077105 |
| TVTX | TRAVERE THERAPEUTICS INC | 200,000 | $3.484M | 0.5% | $17.69 | 0.0% | COM | 89422G107 |
| INSM | INSMED INC | 50,000 | $3.452M | 0.5% | $38.78 | +85.7% | COM PAR $.01 | 457669307 |
| NAMSW | NEWAMSTERDAM PHARMA COMPANY | 237,935 | $3.331M | 0.4% | $5.90 | — | *W EXP 99/99/999 | N62509117 |
| CMPS | COMPASS PATHWAYS PLC | 850,512 | $3.215M | 0.4% | $5.47 | — | SPONSORED ADS | 20451W101 |
| GALT | GALECTIN THERAPEUTICS INC | 2,492,000 | $3.215M | 0.4% | — | — | Put | 363225202 |
| CGEM | CULLINAN THERAPEUTICS INC | 263,817 | $3.213M | 0.4% | $9.11 | +57.9% | COM | 230031106 |
| VRDN | VIRIDIAN THERAPEUTICS INC | 159,614 | $3.06M | 0.4% | $15.63 | +39.1% | COM | 92790C104 |
| MIRM | MIRUM PHARMACEUTICALS INC | 70,742 | $2.925M | 0.4% | $26.72 | +56.0% | COM | 604749101 |
| CGON | CG ONCOLOGY INC | 100,000 | $2.868M | 0.4% | $34.21 | 0.0% | COM | 156944100 |
| TECX | TECTONIC THERAPEUTIC INC | 58,331 | $2.693M | 0.4% | $15.77 | +168.1% | COM | 878972108 |
| BBOT | HELIX ACQUISITION CORP II | 250,000 | $2.625M | 0.4% | $10.35 | +1.5% | CL A ORD SHS | G4444H101 |
| OACCU | OAKTREE ACQUISITION CORP III | 250,000 | $2.538M | 0.3% | $10.15 | — | UNIT 10/04/2029 | G6717R120 |
| IMVT | IMMUNOVANT INC | 100,000 | $2.477M | 0.3% | $22.70 | +24.9% | COM | 45258J102 |
| — | AEROVATE THERAPEUTICS INC | 800,000 | $2.12M | 0.3% | $2.12 | — | COM | 008064107 |
| PCVX | VAXCYTE INC | 25,000 | $2.046M | 0.3% | $61.29 | +62.0% | COM | 92243G108 |
| NKTX | NKARTA INC | 800,000 | $1.992M | 0.3% | $5.54 | -44.3% | COM | 65487U108 |
| — | NEXTCURE INC | 2,302,598 | $1.775M | 0.2% | $1.91 | — | COM | 65343E108 |
| AVR | ANTERIS TECHNOLOGIES GLOBAL | 300,000 | $1.674M | 0.2% | $5.59 | 0.0% | COM | 03675P102 |
| KYMR | KYMERA THERAPEUTICS INC | 40,000 | $1.609M | 0.2% | $45.17 | 0.0% | COM | 501575104 |
| APLS | APELLIS PHARMACEUTICALS INC | 50,000 | $1.595M | 0.2% | $30.07 | 0.0% | COM | 03753U106 |
| — | RAPT THERAPEUTICS INC | 1,000,000 | $1.58M | 0.2% | $1.58 | — | COM | 75382E109 |
| — | INARI MED INC | 25,000 | $1.276M | 0.2% | $49.70 | — | COM | 45332Y109 |
| SVRA | SAVARA INC | 410,586 | $1.26M | 0.2% | $3.79 | -8.0% | COM | 805111101 |
| OKUR | ONKURE THERAPEUTICS INC | 144,159 | $1.24M | 0.2% | $15.14 | 0.0% | COM CL A | 68277Q105 |
| BDTX | BLACK DIAMOND THERAPEUTICS I | 559,163 | $1.197M | 0.2% | $2.87 | 0.0% | COM | 09203E105 |
| CNTX | CONTEXT THERAPEUTICS INC | 1,015,340 | $1.066M | 0.1% | $1.56 | +11.2% | COM | 21077P108 |
| KZR | KEZAR LIFE SCIENCES INC | 142,316 | $956K | 0.1% | $7.45 | 0.0% | COM NEW | 49372L209 |
| CLYM | CLIMB BIO INC | 500,000 | $900K | 0.1% | $6.66 | -45.6% | COM | 28658R106 |
| RADX | RADIOPHARM THERANOSTICS LTD | 156,171 | $684K | 0.1% | $4.38 | — | SPONSORED ADS | 75041J101 |
| IBRX | IMMUNITYBIO INC | 250,000 | $640K | 0.1% | — | — | Put | 45256X103 |
| BMEA | BIOMEA FUSION INC | 150,000 | $582K | 0.1% | — | — | Put | 09077A106 |
| ZURA | ZURA BIO LTD | 223,335 | $558K | 0.1% | $3.54 | +0.5% | CLASS A ORD SHS | G9TY5A101 |
| SYRS | SYROS PHARMACEUTICALS INC | 1,541,200 | $354K | 0.0% | $1.20 | 0.0% | Put | 87184Q206 |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 9,992 | $252K | 0.0% | $32.84 | -17.3% | COM NEW | 15117B202 |
| ADGM | ADAGIO MED HLDGS INC | 213,235 | $224K | 0.0% | $4.76 | -49.3% | COM | 00534B100 |
| — | REPARE THERAPEUTICS INC | 100,000 | $131K | 0.0% | $3.44 | — | COM | 760273102 |
| OMER | OMEROS CORP | 9,958 | $98,385 | 0.0% | $6.86 | 0.0% | COM | 682143102 |
| QTTB | Q32 BIO INC | 27,777 | $95,553 | 0.0% | $13.78 | +129.2% | COM | 746964105 |
| — | IMMATICS N.V | 187,204 | $47,082 | 0.0% | $2.88 | — | *W EXP 07/01/202 | N44445117 |
| SYRS | SYROS PHARMACEUTICALS INC | 150,000 | $34,470 | 0.0% | $1.20 | 0.0% | COM NEW | 87184Q206 |
| SLNO | SOLENO THERAPEUTICS INC | 200 | $8,990 | 0.0% | $51.06 | +1.5% | Call | 834203309 |
| RCKTW | ROCKET PHARMACEUTICALS INC | 75,000 | $2,573 | 0.0% | $0.16 | — | *W EXP 09/02/202 | 77313F114 |